Emerging findings indicate there is a vital cross-talk between gut microbiota and the lungs,
which is known as gut–lung axis. The gut disturbances in lung diseases including allergy …

Inflammatory bowel diseases (IBDs) are a group of chronic gastrointestinal inflammatory
diseases with unknown etiology. There is a combination of well documented factors in their …

Variability in disease presentation, progression and treatment response has been a central
challenge in medicine. Although variability in host factors and genetics are important, it has …

The lungs are not sterile or free from bacteria; rather, they harbor a distinct microbiome
whose composition is driven by different ecological rules than for the gastrointestinal tract …

Fine particulate matter (PM2. 5) exposure causes respiratory diseases by inducing
inflammation and oxidative stress. However, the correlation between the pulmonary …

The composition of intestinal microbiota is influenced by a number of factors, including
medications, which may have a substantial impact on host physiology. Nonsteroidal anti …

Inhaled oxygen, although commonly administered to patients with respiratory disease,
causes severe lung injury in animals and is associated with poor clinical outcomes in …

Recent insights into the bioactivation and signaling actions of inorganic, dietary nitrate and
nitrite now suggest a critical role for the microbiome in the development of cardiac and …

Intermittent fasting (IF) has been reported to have beneficial effects on improving gut function
via lowering gut inflammation and altering the gut microbiome diversity. In this study, we …

A beneficial gut Bacteroides-folate-liver pathway regulating lipid metabolism is
demonstrated. Oral administration of a Ganoderma meroterpene derivative (GMD) …